Back
Castle Biosciences 10K Form
Sell
26
CSTL
Castle Biosciences
Last Price:
$27.09
Seasonality Move:
-4.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-11-09 | 10Q | CSTL/Castle Biosciences Quarterly |
| 2020-08-10 | 10Q | CSTL/Castle Biosciences Quarterly |
| 2020-05-11 | 10Q | CSTL/Castle Biosciences Quarterly |
| 2020-03-10 | 10K | CSTL/Castle Biosciences Annual |
| 2019-11-12 | 10Q | CSTL/Castle Biosciences Quarterly |
| 2019-09-03 | 10Q | CSTL/Castle Biosciences Quarterly |
Receive CSTL News And Ratings
See the #1 stock for the next 7 days that we like better than CSTL
CSTL Financial Statistics
Sales & Book Value
| Annual Sales: | $219.8M |
|---|---|
| Cash Flow: | $17M |
| Price / Cash Flow: | 22.61 |
| Annual Sales: | $15.77 |
| Price / Book: | 1.76 |
Profitability
| EPS (TTM): | 0.21000 |
|---|---|
| Net Income (TTM): | $6.1M |
| Gross Margin: | $174.8M |
| Return on Equity: | 1.49% |
| Return on Assets: | 1.29% |
Castle Biosciences Earnings Forecast
Key Castle Biosciences Financial Ratios
-
The Gross Profit Margin over the past 7 years for CSTL is 79.53%.
-
The Selling, General & Administrative Expenses for CSTL have been equal to 81.97% of Gross Profit Margin.
-
The Research & Development expenses have been 24.40% of Revenue.
-
The Interest Expense is -0.02% of Operating Income.
-
The Net Earning history of CSTL is -26.15% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 3 years.
Castle Biosciences Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | CSTL |
| CUSIP: | 14843C |
| Website: | castlebiosciences.com |
Debt
| Debt-to-Equity Ratio: | 0.02 |
|---|---|
| Current Ratio: | 7.78 |
| Quick Ratio: | 7.45 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CSTL Technical Analysis vs Fundamental Analysis
Sell
26
Castle Biosciences (CSTL)
is a Sell
Is Castle Biosciences a Buy or a Sell?
-
Castle Biosciences stock is rated a SellThe current Castle Biosciences [CSTL] share price is $27.10. The Score for CSTL is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.